Business Context and Reporting Period
This Form 8-K filing by Cardio Diagnostics Holdings, Inc. (CDIO) is dated December 4, 2024. The report addresses a regulatory compliance issue regarding the continued listing of the Company's common stock on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on listing status and regulatory correspondence.
Material Changes
The primary material event is the Company's failure to regain compliance with Nasdaq Listing Rule 5550(a)(2) regarding the Minimum Bid Price Requirement ($1.00 per share) by the initial deadline of December 2, 2024. Consequently, Nasdaq granted the Company an additional 180-day compliance period extending until June 2, 2025.
Guidance, Outlook, and Risks
- Compliance Plan: The Company intends to cure the deficiency during the Second Compliance Period. It plans to consider all available options, including effecting a reverse stock split if necessary.
- Reverse Stock Split Timeline: If a reverse stock split is implemented, it must be completed no later than ten business days prior to the end of the Second Compliance Period (June 2, 2025).
- Delisting Risk: If the Company fails to regain compliance by June 2, 2025, Nasdaq will notify the Company that its securities are subject to delisting. The Company may appeal this determination to the Nasdaq Hearings Panel, though there is no assurance of success.
- Forward-Looking Statements: The filing includes standard disclaimers regarding future intentions and the uncertainty of regulatory outcomes.
Investor Verification Checklist
- Verify the current trading price of CDIO to assess the likelihood of meeting the $1.00 minimum bid price requirement organically.
- Monitor future filings for a formal proposal or shareholder vote regarding a potential reverse stock split.
- Review the Company's latest Form 10-K and 10-Q filings for detailed financial health and liquidity status, as this 8-K does not provide such data.
- Track the June 2, 2025 deadline for the expiration of the Second Compliance Period.